Recent Updates
Recently added Catalysts
SOLV

U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings

Tuesday, July 2, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
Price reaction · baseline $51.45 (2024-07-01 close) · hit after-hours · clean, no other SOLV news in the window
day 0 close · peak
+0.3%

Full Press Release Details

U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings.
ShareAdd on Google
Tags: SOLV Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jul 2, 2024

Biotech snapshot

Cash runway
$403M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ChloraPrep Hi-Lite OrangePhase 3
Bacterial Reduction on Skin Flora Post-product Application →